MedElevator Войти в исследования
← Поиск публикаций

DOI 10.59556/japi.73.1249

Медицинская библиотека · The Journal of the Association of Physicians of India · 2025

Trends in Glomerular Diseases in Northwest India: Has COVID-19 Altered the Diagnostic Landscape?

Singh Abhishek P, Damor Jaydeep R, Beniwal Pankaj, Sharma Sanjeev, Malhotra Vinay, Saxena Puneet

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Glomerular diseases are a major contributor to chronic kidney disease, with regional variability influenced by genetic, environmental, and healthcare factors. In Northwest India, minimal change disease (MCD) was historically the most common primary glomerular disease (PGD). However, evolving diagnostic capabilities and the disruptions caused by the COVID-19 pandemic may have altered the landscape of glomerular disease presentations and biopsy practices.

OBJECTIVES

To reassess the clinicopathologic spectrum of glomerular diseases from 2020 to 2024, compare it with data from 2008 to 2013, and evaluate the impact of the COVID-19 pandemic on biopsy activity and disease distribution.

METHODOLOGY: We retrospectively analyzed 925 renal biopsies from 2020 to 2024 and compared them with 622 biopsies from 2008 to 2013. All samples underwent light microscopy (LM) and immunofluorescence (IF) staining (IgA, IgG, IgM, C3, and C4). Diagnoses were categorized into PGD, secondary glomerular disease (SGD), and others. Clinical presentations, including nephrotic syndrome (NS) and acute kidney injury (AKI), were recorded. Statistical comparisons were made using Chi-square (χ2) and Z-tests (SPSS v29), with p < 0.05 considered significant.

RESULTS

Glomerulonephritis remained predominant (93.9%) with a significant shift in distribution (χ2 = 121.5, p < 0.0001). IgA nephropathy increased from 7.4 to 15.4%, overtaking MCD (which declined from 21.1 to 8.1%) as the leading PGD. Focal segmental glomerulosclerosis (FSGS) rose to 12.4%, while diabetic nephropathy (DN) increased to 3.1%. Nephrotic syndrome was the most common presentation (59.3%). Biopsy volume declined by 60% in 2020 but rebounded by 2022.

CONCLUSION

These findings highlight evolving diagnostic trends and underscore the need for broader biopsy access, enhanced diagnostic tools, and a national renal biopsy registry in India.

Для цитирования: Singh Abhishek P, Damor Jaydeep R, Beniwal Pankaj, Sharma Sanjeev, Malhotra Vinay, Saxena Puneet. Trends in Glomerular Diseases in Northwest India: Has COVID-19 Altered the Diagnostic Landscape?. The Journal of the Association of Physicians of India. 2025. DOI: 10.59556/japi.73.1249.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.